Medicare Enrolled
Dr. Ronald Wainz, M.D.
Pulmonary Disease · Toledo, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wainz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wainz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wainz
Dr. Ronald Wainz is a pulmonary disease specialist in Toledo, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Wainz performed 1,608 Medicare services across 1,372 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wainz received a total of $8,496 from 58 pharmaceutical and/or device companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wainz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 11% volume in OH
$8,496 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,608
Medicare services
Top 11% in OH for pulmonary disease
1,372
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
319 | $61 | $112 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
255 | $22 | $60 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
219 | $27 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
154 | $91 | $165 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
117 | $8 | $46 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
115 | $62 | $127 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
103 | $8 | $25 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
60 | $94 | $182 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
47 | $6 | $59 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $100 | $239 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
32 | $14 | $23 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
31 | $34 | $146 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $129 | $315 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
26 | $91 | $258 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
19 | $8 | $25 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
19 | $96 | $268 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $70 | $147 |
| Lung airway sensitivity test A test used to measure the sensitivity of the airways in the lungs. |
11 | $22 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,496
Total received (2018-2024)
Avg $1,214/year across 7 years
Top 19% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
442
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,978 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$519 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$930
2023
$1,789
2022
$1,594
2021
$898
2020
$529
2019
$1,600
2018
$1,155
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$216
INTUITIVE SURGICAL, INC.
$129
GlaxoSmithKline, LLC.
$96
PFIZER INC.
$65
La Jolla Pharmaceutical Company
$47
Janssen Pharmaceuticals, Inc
$44
GENZYME CORPORATION
$42
United Therapeutics Corporation
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
INOGEN, INC.
$30
ABBVIE INC.
$24
AIMMUNE THERAPEUTICS, INC.
$23
Mylan Specialty L.P.
$22
ANI Pharmaceuticals, Inc.
$21
Actelion Pharmaceuticals US, Inc.
$19
Amgen Inc.
$19
Phadia US Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$15
Inspire Medical Systems, Inc.
$14
3B Medical, Inc.
$14
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,008
GlaxoSmithKline, LLC.
$998
Insmed, Inc.
$677
Boehringer Ingelheim Pharmaceuticals, Inc.
$599
Vertex Pharmaceuticals Incorporated
$310
Mylan Specialty L.P.
$294
Mallinckrodt Hospital Products Inc.
$284
Genentech USA, Inc.
$272
Grifols USA, LLC
$247
CSL Behring
$238
Baxter Healthcare
$238
United Therapeutics Corporation
$203
Actelion Pharmaceuticals US, Inc.
$195
GENZYME CORPORATION
$189
VERTEX PHARMACEUTICALS INCORPORATED
$174
SANOFI-AVENTIS U.S. LLC
$160
Sunovion Pharmaceuticals Inc.
$154
Janssen Pharmaceuticals, Inc
$152
La Jolla Pharmaceutical Company
$139
INTUITIVE SURGICAL, INC.
$129
Takeda Pharmaceuticals U.S.A., Inc.
$122
Merck Sharp & Dohme Corporation
$121
Amgen Inc.
$111
Regeneron Healthcare Solutions, Inc.
$111
Philips Electronics North America Corporation
$108
Inogen, Inc.
$84
AbbVie, Inc.
$81
ADVANCED RESPIRATORY, INC
$75
Harmony Biosciences LLC
$71
Gilead Sciences, Inc.
$69
PFIZER INC.
$65
Nestle HealthCare Nutrition Inc.
$56
JAZZ PHARMACEUTICALS INC.
$55
Advanced Respiratory, Inc
$53
Jazz Pharmaceuticals Inc.
$50
Shionogi Inc
$49
Novartis Pharmaceuticals Corporation
$46
Alexion Pharmaceuticals, Inc.
$45
Phadia US Inc.
$35
Chiesi USA, Inc.
$34
Electromed, Inc.
$33
Astellas Pharma US Inc
$31
INOGEN, INC.
$30
Teva Pharmaceuticals USA, Inc.
$29
Allergan Inc.
$27
Covis Pharma GmBH
$26
ABBVIE INC.
$24
AIMMUNE THERAPEUTICS, INC.
$23
Resmed Corp
$21
ANI Pharmaceuticals, Inc.
$21
Pharming Healthcare, Inc.
$19
Paratek Pharmaceuticals, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Circassia Pharmaceuticals Inc
$16
Abbott Laboratories
$14
Axsome Therapeutics, Inc.
$14
Inspire Medical Systems, Inc.
$14
3B Medical, Inc.
$14
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ALVESCO · ANORO · AREXVY · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · Astral · BETHKIS · BREO · BREZTRI · BRONCHITOL · BROVANA · CREON · CUVITRU · Creon · DUPIXENT · Da Vinci Surgical System · Esbriet · FASENRA · Fetroja · GIAPREZA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · I-STAT · IMFINZI · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · LEXISCAN · LINZESS · LONHALA MAGNAIR · LUNA · MYCAMINE · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · ORKAMBI · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · QVAR · REMODULIN · RUCONEST · SEEBRI NEOHALER · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYMDEKO · Sunosi · TEZSPIRE · TOBI PODHALER · TRELEGY ELLIPTA · TRIKAFTA · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · Utibron · Veklury · Wakix · XACDURO · XARELTO · XERAVA · XOLAIR · XYREM · Xolair · YUPELRI · Yupelri · ZENPEP · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
27
Per 100K population
6.3
County median income
$60,095
Nearest hospital
PROMEDICA TOLEDO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wainz is a clinical cardiology specialist, with above-average Medicare volume (top 11% in OH), with low-engagement industry engagement in the top 19% of OH peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wainz experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Wainz performed 319 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wainz receive payments from pharmaceutical companies?
Yes. Dr. Wainz received a total of $8,496 from 58 companies across 442 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wainz's costs compare to other pulmonary diseases in Toledo?
Dr. Wainz's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wainz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Toledo
Browse pulmonary diseases in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in OH
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in OH
Which OH pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology